"Removing compounded Semaglutide with no public input, and no consideration of what's actually happening on the ground, is indefensible," said Julia Cantu, attorney for NP2Go
Pregnancy and Breastfeeding: Mounjaro is not recommended during pregnancy or breastfeeding, and its advised to discontinue use if planning to become pregnant
Food and Drug Administration (FDA) has not issued a statement regarding whether it will also investigate or act on these findings
And another study from George Washington University found that people on GLP-1 medications had a higher risk of experiencing hair loss
However, if you experience any side effects, please consult a doctor
Inhibitors of protein disulfide isomerase suppress apoptosis induced by misfolded proteins